Why the study?
Are there differences in thrombotic and fibrinolytic markers between the left atrium, right atrium, and peripheral vein in patients with mitral stenosis?
Are there differences in thrombotic and fibrinolytic markers between the left atrium, right atrium, and peripheral vein in patients with mitral stenosis?
This small study measured thrombotic and fibrinolytic markers in different cardiac chambers of patients with mitral stenosis to investigate local hypercoagulability.
Answers are grounded in this paper and cite their sources.
Local marker profiling in mitral stenosis remains hypothesis-generating; larger studies needed before clinical implications can be drawn.
To the Editor: Thromboembolism is a frequent and serious complication of valvular heart disease, particularly mitral stenosis1,2. Recently, sensitive molecular markers for assessing thrombotic and fibrinolytic states have been identified3. We measured the levels of these markers in blood from a peripheral vein, the right atrium, and the left atrium of eight patients with mitral stenosis who were undergoing percutaneous mitral valvuloplasty. The study group consisted of three men and five women (mean age, 53 years; range, 39 to 61) with rheumatic mitral stenosis (mean mitral-valve area, 0.69 ±0.06 cm2) but without left atrial thrombus. Seven . . .
No takes yet. Share an insight, caveat, or question.
Yamamoto et al. (1993) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: